期刊文献+

Adiponectin gene polymorphisms and risk of gestational diabetes mellitus:A meta-analysis 被引量:4

Adiponectin gene polymorphisms and risk of gestational diabetes mellitus:A meta-analysis
下载PDF
导出
摘要 BACKGROUND Adiponectin(ADIPOQ) is an important factor involved in the regulation of both carbohydrate and lipid metabolism. Polymorphisms in the ADIPOQ gene are known to influence an individual's predisposition to metabolic syndrome and type 2 diabetes. Moreover, women with gestational diabetes mellitus(GDM) are at an increased risk of developing type 2 diabetes. Several studies have been conducted previously to assess the association between ADIPOQ polymorphisms and GDM; however, the results of the association are inconclusive.AIM To quantitatively evaluate the association between ADIPOQ +45 T/G, +276 G/T,and-11377 C/G polymorphisms and the risk of GDM.METHODS A systematic search of EMBASE, PubMed, CNKI, Web of Science, and WANFANG DATA was conducted up to October 20, 2018. We calculated merged odds ratios(ORs) with 95% confidence intervals(CIs) using a fixed-effects or random-effects model depending on the between-study heterogeneity to evaluate the association between AIDPOQ +45 T/G, +276 G/T, and-11377 C/G polymorphisms and the risk of GDM. Subgroup analysis was performed by ethnicity. Publication and sensitivity bias analyses were performed to test the robustness of the association. All statistical analyses were conducted using Stata 12.0.RESULTS Nine studies of +45 T/G included 1024 GDM cases and 1059 controls, five studies of +276 G/T included 590 GDM cases and 595 controls, and five studies of-11377 C/G included 722 GDM cases and 791 controls. Pooled ORs indicated that+45 T/G increased GDM risk in Asians(allelic model: OR = 1.47, 95%CI: 1.27-1.70,P = 0.000; dominant model: OR = 1.54, 95%CI: 1.27-1.85, P = 0.000; recessive model: OR=2.00, 95%CI: 1.43-2.85, P = 0.000), not in South Americans(allelic model: OR = 1.21, 95%CI: 0.68-2.41, P = 0.510; dominant model: OR = 1.13, 95%CI:,0.59-2.15, P = 0.710; recessive model: OR = 2.18, 95%CI: 0.43-11.07, P = 0.350).There were no significant associations between +276 G/T(allelic model: OR = 0.88,95%CI: 0.74-1.05, P = 0.158; dominant model: OR = 0.91, 95%CI: 0.65-1.26, P =0.561; recessive model: OR = 0.82, 95%CI: 0.64-1.05, P = 0.118) or-11377 C/G(allelic model: OR = 0.96, 95%CI: 0.72-1.26, P = 0.750; dominant model: OR = 1.00,95%CI: 0.73-1.37, P = 0.980; recessive model: OR = 0.90, 95%CI: 0.61-1.32, P =0.570) and the risk of GDM.CONCLUSION Our meta-analysis shows the critical role of the ADIPOQ +45 T/G polymorphism in GDM, especially in Asians. Studies focused on delineating ethnicity-specific factors with larger sample sizes are needed. BACKGROUND Adiponectin(ADIPOQ) is an important factor involved in the regulation of both carbohydrate and lipid metabolism. Polymorphisms in the ADIPOQ gene are known to influence an individual's predisposition to metabolic syndrome and type 2 diabetes. Moreover, women with gestational diabetes mellitus(GDM) are at an increased risk of developing type 2 diabetes. Several studies have been conducted previously to assess the association between ADIPOQ polymorphisms and GDM; however, the results of the association are inconclusive.AIM To quantitatively evaluate the association between ADIPOQ +45 T/G, +276 G/T,and-11377 C/G polymorphisms and the risk of GDM.METHODS A systematic search of EMBASE, PubMed, CNKI, Web of Science, and WANFANG DATA was conducted up to October 20, 2018. We calculated merged odds ratios(ORs) with 95% confidence intervals(CIs) using a fixed-effects or random-effects model depending on the between-study heterogeneity to evaluate the association between AIDPOQ +45 T/G, +276 G/T, and-11377 C/G polymorphisms and the risk of GDM. Subgroup analysis was performed by ethnicity. Publication and sensitivity bias analyses were performed to test the robustness of the association. All statistical analyses were conducted using Stata 12.0.RESULTS Nine studies of +45 T/G included 1024 GDM cases and 1059 controls, five studies of +276 G/T included 590 GDM cases and 595 controls, and five studies of-11377 C/G included 722 GDM cases and 791 controls. Pooled ORs indicated that+45 T/G increased GDM risk in Asians(allelic model: OR = 1.47, 95%CI: 1.27-1.70,P = 0.000; dominant model: OR = 1.54, 95%CI: 1.27-1.85, P = 0.000; recessive model: OR=2.00, 95%CI: 1.43-2.85, P = 0.000), not in South Americans(allelic model: OR = 1.21, 95%CI: 0.68-2.41, P = 0.510; dominant model: OR = 1.13, 95%CI:,0.59-2.15, P = 0.710; recessive model: OR = 2.18, 95%CI: 0.43-11.07, P = 0.350).There were no significant associations between +276 G/T(allelic model: OR = 0.88,95%CI: 0.74-1.05, P = 0.158; dominant model: OR = 0.91, 95%CI: 0.65-1.26, P =0.561; recessive model: OR = 0.82, 95%CI: 0.64-1.05, P = 0.118) or-11377 C/G(allelic model: OR = 0.96, 95%CI: 0.72-1.26, P = 0.750; dominant model: OR = 1.00,95%CI: 0.73-1.37, P = 0.980; recessive model: OR = 0.90, 95%CI: 0.61-1.32, P =0.570) and the risk of GDM.CONCLUSION Our meta-analysis shows the critical role of the ADIPOQ +45 T/G polymorphism in GDM, especially in Asians. Studies focused on delineating ethnicity-specific factors with larger sample sizes are needed.
出处 《World Journal of Clinical Cases》 SCIE 2019年第5期572-584,共13页 世界临床病例杂志
基金 Supported by the National Nature Science Foundation of China,No.81773535
关键词 GESTATIONAL diabetes MELLITUS Single NUCLEOTIDE POLYMORPHISM ADIPONECTIN Gene META-ANALYSIS Gestational diabetes mellitus Single nucleotide Polymorphism Adiponectin Gene Meta-analysis
  • 相关文献

参考文献7

二级参考文献46

  • 1刘德敏,靳立忠,于德民,李戈,张捷.2型糖尿病患者中脂联素基因多态性的研究[J].中华糖尿病杂志(1006-6187),2004,12(6):397-398. 被引量:24
  • 2刘楼,孙丽洲,许建娟.脂联素基因多态性和妊娠期糖尿病的相关性研究[J].广东医学,2006,27(12):1822-1824. 被引量:9
  • 3王淑芳,赵家军,姜强,高聆,马慧.脂联素基因多态性与2型糖尿病相关性研究[J].中华内分泌代谢杂志,2007,23(1):51-52. 被引量:21
  • 4王吉影,王艳波,于永春,李智,滕小洪,王红玲.2型糖尿病家系脂联素基因多态性研究[J].第二军医大学学报,2007,28(2):143-147. 被引量:7
  • 5孙伟杰,杨慧霞.妊娠合并糖代谢异常孕妇的妊娠结局分析[J].中华妇产科杂志,2007,42(6):377-381. 被引量:97
  • 6Rajala MW, Schere PE. Minereview.. The adipocyte -at the crossroads of energy homeostasis, inflammation, and atherosclerosis[J]. Endocrinology, 2003,144(9) :3765-3773.
  • 7Retnakaran R,Hanley AJ,Raif N,et al. Adiponectin and beta cell dysfunction in gestational diabetes., pathophysiological implications[J]. Diabetologia, 2005,48(5) : 993-1001.
  • 8Cartegni L, Chew SL, Krainer AR. Listening to silence and understanding nonsense: exonic mutations that afect splicing [J]. Nat Rev Genet, 2002,3(4) : 285-298.
  • 9Vasseur F, Helbecque N, Dina C, et al. Single-nueleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians [J]. Hum Mol Genet, 2002,11(21) : 2607-2614.
  • 10Hara K,Boutin P,Mori Y,et al. Genetic variation in the gene encocliffg adiponectin is associated with an increased risk of type 2 diabete~ in the Japanese population[J]. Diabetes, 2002, 51 (2) :536-540.

共引文献31

同被引文献31

引证文献4

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部